Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.59 |
| ▸ | SLC7A5 | Q01650 | 8/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.59 |
| ▸ | ALPI | P09923 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | XIAP | P98170 | 1/20 | 0.59 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.56 |
| ▸ | DPP4 | P27487 | 2/20 | 0.56 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.56 |
| ▸ | FAP | Q12884 | 1/20 | 0.56 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.56 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.56 |
| ▸ | NOS3 | P29474 | 2/20 | 0.55 |
| ▸ | NOS1 | P29475 | 2/20 | 0.55 |
| ▸ | NOS2 | P35228 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | EGFR | P00533 | 1/20 | 0.51 |
| ▸ | LCK | P06239 | 1/20 | 0.51 |
| ▸ | FYN | P06241 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29557415 | 1.00 | FOLH1 (0.59) | FOLH1SLC7A5PTGS1ALPIPKM | |
| SCHEMBL838038 | 1.00 | FOLH1 (0.59) | FOLH1SLC7A5PTGS1ALPIPKM | |
| SCHEMBL29397955 | 1.00 | FOLH1 (0.59) | FOLH1SLC7A5PTGS1ALPIPKM | |
| SCHEMBL43812 | 1.00 | FOLH1 (0.59) | FOLH1SLC7A5PTGS1ALPIPKM | |
| Ammonia Solution, Strong SCHEMBL3564413 | 0.98 | FOLH1 (0.58) | FOLH1SLC7A5PTGS1ALPIPKM | |
| Hydrochloric Acid SCHEMBL7591933 | 0.98 | FOLH1 (0.58) | FOLH1SLC7A5PTGS1ALPIPKM | |
| Ammonia Solution, Strong SCHEMBL3564410 | 0.98 | FOLH1 (0.58) | FOLH1SLC7A5PTGS1ALPIPKM | |
| Ammonia Solution, Strong SCHEMBL3564412 | 0.98 | FOLH1 (0.58) | FOLH1SLC7A5PTGS1ALPIPKM | |
| Hydrochloric Acid SCHEMBL7042048 | 0.98 | FOLH1 (0.58) | FOLH1SLC7A5PTGS1ALPIPKM | |
| Hydrochloric Acid SCHEMBL27695050 | 0.98 | FOLH1 (0.58) | FOLH1SLC7A5PTGS1ALPIPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1330 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4619043-A1 | FIBROBLAST ACTIVATION PROTEIN TARGETED COMPOUNDS AND USE THEREOF | Perspective Therapeutics, Inc. (US) | 2025-09-24 | — | — | EP | claimed |
| WO-2025128149-A1 | FIBROBLAST ACTIVATION PROTEIN TARGETED COMPOUNDS AND USE THEREOF | VIEWPOINT MOLECULAR TARGETING, INC. (US) | 2025-06-19 | — | — | WO | claimed |
| US-20250186630-A1 | FIBROBLAST ACTIVATION PROTEIN TARGETING PEPTIDES | VIEWPOINT MOLECULAR TARGETING, INC. (US) | 2025-06-12 | — | — | US | claimed |
| US-12084476-B2 | Tailored cyclodepsipeptides as potent non-covalent serine protease inhibitors | Universität Duisburg-Essen (DE) | 2024-09-10 | — | — | US | claimed |
| CN-113481228-B | Microbial unnatural amino acid introducing system and construction method | 中国药科大学 | 2024-07-19 | — | — | CN | claimed |
| EP-3625243-B1 | TAILORED CYCLODEPSIPEPTIDES AS POTENT NON-COVALENT SERINE PROTEASE INHIBITORS | UNIV DUISBURG ESSEN (DE) | 2023-10-18 | — | — | EP | claimed |
| WO-2023042201-A1 | ANTIMICROBIAL PEPTIDES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2023-03-23 | — | — | WO | claimed |
| CN-111118048-B | Use of chimeric phenylalanyl-tRNA synthetases/tRNAs | 浙江大学 | 2022-06-10 | — | — | CN | claimed |
| US-20220002348-A1 | TAILORED CYCLODEPSIPEPTIDES AS POTENT NON-COVALENT SERINE PROTEASE INHIBITORS | Universität Duisburg-Essen (DE) | 2022-01-06 | — | — | US | claimed |
| CN-113481228-A | Microorganism unnatural amino acid introduction system and construction method | 中国药科大学 | 2021-10-08 | — | — | CN | claimed |
| US-20080039626-A1 | Method for Cleaning 3-Hydroxyamidinophenylalanine Derivatives by the Precepitation and Recrystallization of Salt and an Aromatic Sulfonic Acid | WILEX AG (DE) | 2008-02-14 | — | — | US | claimed |
| US-7247724-B2 | Method for the production of phenylalanine derivatives | WILEX AG (DE) | 2007-07-24 | — | — | US | claimed |
| EP-1799665-A1 | METHOD FOR CLEANING 3-HYDROXYAMIDINOPHENYLALANINE DERIVATIVES BY THE PRECIPITATION AND RECRYSTALLISATION OF A SALT AND AN AROMATIC SULPHONIC ACID | Wilex AG (DE) | 2007-06-27 | — | — | EP | claimed |
| WO-2006042678-A1 | METHOD FOR CLEANING 3-HYDROXYAMIDINOPHENYLALANINE DERIVATIVES BY THE PRECIPITATION AND RECRYSTALLISATION OF A SALT AND AN AROMATIC SULPHONIC ACID | WILEX AG (DE) | 2006-04-27 | — | — | WO | claimed |
| WO-2005122379-A9 | ALPHA-4 BETA-1 INTEGRIN LIGANDS FOR IMAGING AND THERAPY | UNIV CALIFORNIA (US) | 2006-03-09 | — | — | WO | claimed |
| US-20060019900-A1 | Alpha-4 beta-1 integrin ligands for imaging and therapy | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-01-26 | — | — | US | claimed |
| WO-2005122379-A2 | ALPHA-4 BETA-1 INTEGRIN LIGANDS FOR IMAGING AND THERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-12-22 | — | — | WO | claimed |
| US-20050245757-A1 | Method for the production of phenylalanine derivatives | WILEX AG (DE) | 2005-11-03 | — | — | US | claimed |
| EP-1525195-A2 | METHOD FOR THE PRODUCTION OF PHENYLALANINE DERIVATIVES | Wilex AG (DE) | 2005-04-27 | — | — | EP | claimed |
| WO-2004011449-A2 | METHOD FOR THE PRODUCTION OF PHENYLALANINE DERIVATIVES | WILEX AG (DE) | 2004-02-05 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060019900-A1 | Alpha-4 beta-1 integrin ligands for imaging and therapy | ITGA4, ITGB4, ITGA1 | FOLH1 1163/4885SLC7A5 576/4885PTGS1 3492/4885 |
| US-12084476-B2 | Tailored cyclodepsipeptides as potent non-covalent serine protease inhibitors | HTRA1, LNPEP, ENPEP | FOLH1 270/4885SLC7A5 1601/4885PTGS1 552/4885 |
| US-20250186630-A1 | FIBROBLAST ACTIVATION PROTEIN TARGETING PEPTIDES | FAP, FIBP, TPX2 | FOLH1 177/4885SLC7A5 938/4885PTGS1 3788/4885 |
| US-20220002348-A1 | TAILORED CYCLODEPSIPEPTIDES AS POTENT NON-COVALENT SERINE PROTEASE INHIBITORS | HTRA1, LNPEP, ENPEP | FOLH1 270/4885SLC7A5 1601/4885PTGS1 552/4885 |
| US-20050245757-A1 | Method for the production of phenylalanine derivatives | PAH, NPEPPS, DNPEP | FOLH1 195/4885SLC7A5 260/4885PTGS1 2513/4885 |
| US-20080039626-A1 | Method for Cleaning 3-Hydroxyamidinophenylalanine Derivatives by the Precepitation and Recrystallization of Salt and an Aromatic Sulfonic Acid | PEPD, PAH, PRSS3 | FOLH1 166/4885SLC7A5 618/4885PTGS1 4086/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.